Publications
- ALK-positive advanced non-small cell lung cancer patient with poor performance status - case report2023 | Third Faculty of Medicine
- Amivantamab in non‐small cell lung cancer treatment2023 | Third Faculty of Medicine
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
- Laboratory Parameters Associated with Inflammation Do Not Affect PD-L1 Expression in Non-small Cell Lung Cancer2022 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
- First-line treatment for non-squamous NSCLC without driver mutations2022 | Third Faculty of Medicine
- Comparison of Chemotherapeutic Regimens Frequently Used in Metastatic Non-squamous NSCLC Treatment2021 | Third Faculty of Medicine, Faculty of Medicine in Pilsen, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- New treatment modalities in the early stage and locally advanced non-small cell lung cancer2021 | Third Faculty of Medicine, First Faculty of Medicine
- Treatment options for non-small cell lung stage III cancer2021 | Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Lambert-Eaton myasthenic syndrome and small cell lung cancer - case report +12021 | Third Faculty of Medicine
Loading network view...